Ventricular Septal Defects Clinical Trial
The AMPLATZER Muscular VSD Occluder was approved by the US Food and Drug Administration (FDA) in September, 2007. This study is designed to further evaluate the safety and effectiveness in subjects implanted with the AMPLATZER Muscular VSD Occluder.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00229827 -
Optimal Timing for Repair of Left to Right Shunt Lesions
|
N/A | |
Completed |
NCT00890799 -
Transcatheter Closure Versus Surgery of Perimembranous Ventricular Septal Defects
|
N/A | |
Completed |
NCT02552485 -
Evaluation of Latent Pulmonary Arterial Hypertension in Congenital Shunt Lesions
|
N/A |